Loading
HI
Histogen Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Pascoe Richard W, was filed 30 Mar 2021.
Histogen Inc.: what insiders have been doing
Histogen Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Histogen Inc. The previous disclosure was published on 30 March 2021.
Looking back to 2016, when coverage begins, insiders filed 2 purchases and no sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
29
Thresholds
n/a
Buy Volume
€29,679
2 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
Revenue3.4M
Net income-10.1M-302.1% margin
Last declaration on 30 March 2021
Declarations29 total
20,000 shares@ US$1.1465.5% of flowCommon StockSEC:0001209191-21-023623:0
Canonical exit: 28 Jun 2021 (T+90)
10,000 shares@ US$1.2394100.0% of flowCommon StockSEC:0001209191-20-061926:0
Canonical exit: 3 Mar 2021 (T+90)
11,951 shares0Common StockSEC:0000899243-20-014475:0
14,485 shares0Common StockSEC:0000899243-20-014471:0
426,526 shares0Common StockSEC:0000899243-20-014479:0
2,356,597 shares0Common StockSEC:0000899243-20-014472:0
1,434 shares0Common StockSEC:0000899243-20-014477:0
600,983 shares0Common StockSEC:0000899243-20-014470:0
18,615 shares@ US$0.56100.0% of flowCommon StockSEC:0000899243-20-014293:1
31,428 shares@ US$0.56100.0% of flowCommon StockSEC:0000899243-20-014288:1
12,960 shares@ US$0.56100.0% of flowCommon StockSEC:0000899243-20-014290:1
38,500 shares0Common StockSEC:0000899243-20-014293:0
65,000 shares0Common StockSEC:0000899243-20-014288:0
31,343 shares0Common StockSEC:0000899243-20-014290:0
1,290 shares@ US$3.3128.9% of flowCommon StockSEC:0001209191-19-008924:0
1,861 shares@ US$3.1541.8% of flowCommon StockSEC:0001209191-19-008924:1
4,690 shares@ US$3.3141.8% of flowCommon StockSEC:0001209191-19-008925:0
1,724 shares@ US$3.1515.4% of flowCommon StockSEC:0001209191-19-008925:1
60,000 shares@ US$0.9943.6% of flowCommon StockSEC:0001209191-18-028454:0
12,121 shares@ US$1.2464.8% of flowCommon StockSEC:0001209191-18-014949:0
4,461 shares@ US$3.4842.8% of flowCommon StockSEC:0001209191-18-007562:0
761 shares@ US$1.709.6% of flowCommon StockSEC:0001209191-18-007561:0
818 shares@ US$3.4819.7% of flowCommon StockSEC:0001209191-18-007561:1
42,424 shares@ US$0.99100.0% of flowCommon StockSEC:0001209191-17-003344:0
2,310 shares0Common StockSEC:0001209191-16-157110:0
25 of 29 declarations
About Histogen Inc.
Histogen Inc. is a biopharmaceutical company that develops therapies based on biological products to treat degenerative diseases. It focuses on tissue regeneration and restoring cellular functions.
